{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:45:20Z","timestamp":1791229520778,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jpurol.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T20:35:11Z","timestamp":1645130111000},"page":"351.e1-351.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Intravesical botulinum-A toxin in children with refractory non-neurogenic overactive bladder"],"prefix":"10.1016","volume":"18","author":[{"given":"Annemarth P.","family":"Lambregts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anka J.","family":"Nieuwhof-Leppink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aart J.","family":"Klijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier P.J.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpurol.2022.02.007_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/nau.22751","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the International Children's Continence Society","volume":"35","author":"Austin","year":"2016","journal-title":"Neurourol Urodyn"},{"issue":"9","key":"10.1016\/j.jpurol.2022.02.007_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nrurol.2016.152","article-title":"Overactive bladder in children","volume":"13","author":"Franco","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"7","key":"10.1016\/j.jpurol.2022.02.007_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S2352-4642(19)30113-0","article-title":"Daytime urinary incontinence in children and adolescents","volume":"3","author":"Nieuwhof-Leppink","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jpurol.2022.02.007_bib4","article-title":"Definitions, indications and practice of urotherapy in children and adolescents: a standardization document of the International Children's Continence Society (ICCS)","author":"Nieuwhof-Leppink","year":"2020","journal-title":"J Pediatr Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2022.02.007_bib5","doi-asserted-by":"crossref","first-page":"21.e1","DOI":"10.1016\/j.jpurol.2014.06.024","article-title":"Central inhibition of refractory overactive bladder complaints, results of an inpatient training program","volume":"11","author":"Meijer","year":"2015","journal-title":"J Pediatr Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2022.02.007_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0970-1591.109975","article-title":"The use of botulinum toxin for the treatment of overactive bladder syndrome","volume":"29","author":"Orasanu","year":"2013","journal-title":"Indian J Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.jpurol.2022.02.007_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.jpurol.2022.02.007_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.jpurol.2022.02.007_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0029-1246193","article-title":"Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children","volume":"20","author":"Marte","year":"2010","journal-title":"Eur J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.jpurol.2022.02.007_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-5347(06)00301-6","article-title":"The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor","volume":"176","author":"Hoebeke","year":"2006","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.jpurol.2022.02.007_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jpedsurg.2018.05.012","article-title":"Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: a preliminary report","volume":"54","author":"Al Edwan","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"6","key":"10.1016\/j.jpurol.2022.02.007_bib12","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0022-5347(06)00331-4","article-title":"Home uroflowmetry biofeedback in behavioral training for dysfunctional voiding in school-age children: a randomized controlled study","volume":"175","author":"Klijn","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.jpurol.2022.02.007_bib13","doi-asserted-by":"crossref","first-page":"32.e1","DOI":"10.1016\/j.jpurol.2018.08.007","article-title":"Onabotulinum toxin A in children with refractory idiopathic overactive bladder: medium-term outcomes","volume":"15","author":"Ingham","year":"2019","journal-title":"J Pediatr Urol"},{"issue":"2","key":"10.1016\/j.jpurol.2022.02.007_bib14","doi-asserted-by":"crossref","first-page":"181.e1","DOI":"10.1016\/j.jpurol.2019.12.013","article-title":"Intradetrusor onabotulinum-a toxin injections in children with therapy-resistant idiopathic detrusor overactivity. A retrospective study","volume":"16","author":"Ringoir","year":"2020","journal-title":"J Pediatr Urol"},{"issue":"6 Pt A","key":"10.1016\/j.jpurol.2022.02.007_bib15","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jpurol.2012.08.011","article-title":"Intravesical botulinum type-A toxin (Dysport\u00ae) in the treatment of idiopathic detrusor overactivity in children","volume":"9","author":"Blackburn","year":"2013","journal-title":"J Pediatr Urol"},{"issue":"3","key":"10.1016\/j.jpurol.2022.02.007_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00383-011-3039-5","article-title":"Urinary incontinence in children: botulinum toxin is a safe and effective treatment option","volume":"28","author":"McDowell","year":"2012","journal-title":"Pediatr Surg Int"},{"issue":"8","key":"10.1016\/j.jpurol.2022.02.007_bib17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s11255-018-1926-6","article-title":"Non-invasive evaluation of botulinum-A toxin treatment efficacy in children with refractory overactive bladder","volume":"50","author":"U\u00e7ar","year":"2018","journal-title":"Int Urol Nephrol"},{"issue":"6 Pt B","key":"10.1016\/j.jpurol.2022.02.007_bib18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.jpurol.2013.03.011","article-title":"Efficacy and safety of urethral de-obstruction in boys with overactive bladder complaints","volume":"9","author":"de Jong","year":"2013","journal-title":"J Pediatr Urol"},{"issue":"12","key":"10.1016\/j.jpurol.2022.02.007_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/1756287218801282","article-title":"Mirabegron, alone and in combination, in the treatment of overactive bladder: real-world evidence and experience","volume":"10","author":"Allison","year":"2018","journal-title":"Ther Adv Urol"},{"issue":"4","key":"10.1016\/j.jpurol.2022.02.007_bib20","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.juro.2016.11.101","article-title":"Dual therapy for refractory overactive bladder in children: a prospective open-label study","volume":"197","author":"Morin","year":"2017","journal-title":"J Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513122000699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513122000699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:51:39Z","timestamp":1761486699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513122000699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1477513122000699"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2022.02.007","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravesical botulinum-A toxin in children with refractory non-neurogenic overactive bladder","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of Journal of Pediatric Urology Company.","name":"copyright","label":"Copyright"}]}}